CARIE BROWN: Open Payments
NPI 1750849758 · KENANSVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,413 in 86 payments from 22 companies in 2025. Trend: 2023 $1,539 · 2024 $1,440 · 2025 $1,413
Food & beverage: $1,413
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $160 |
| Aimmune Therapeutics, Inc. | 7 | $152 |
| Novo Nordisk Inc | 10 | $151 |
| Astellas Pharma US Inc | 8 | $149 |
| ABBVIE INC. | 16 | $137 |
| PFIZER INC. | 4 | $75 |
| Sumitomo Pharma America, Inc. | 4 | $73 |
| Corcept Therapeutics | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| Axsome Therapeutics, Inc. | 3 | $53 |
Products named: ZENPEP, Veozah, AIRSUPRA, QULIPTA, NURTEC ODT, GEMTESA, Wegovy, Korlym.
Industry payments across NC — which companies pay providers there.
